“ipos” Archives

in
Entry Author Date Location
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Dramatic Capital Inflows Continue in 2Q17… Trouble Ahead? 08/03/17 Boston
U.S. IPOs Surge Amid Nettlesome Risks; Top 10 Deals So Far in 2017 06/28/17 National
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Trump Policies, Paperwork, & More: Advice for Startup Founders 02/24/17 Wisconsin
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Epic, VC Totals, Shine, & More: This Week’s Wisconsin Watchlist 01/17/17 Wisconsin
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge 11/22/16 National
With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors 11/01/16 Boulder/Denver
With Insider Help, Ra Pharma Upsizes IPO, Bags $92M 10/25/16 Boston
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Twilio’s $150M IPO May Bolster Faith In Unicorns—-Or Some Of Them 06/23/16 San Francisco
Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case 06/22/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
The Big Value Creation Trend of 2015: Q&A with Jonathan Medved 12/22/15 National
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Bio Slump Hits IPOs as Edge, Mirna Cut Prices, Upsize to Close Deals 10/01/15 New York
Page 1 of 18 next page »